Elite Pharmaceuticals Inc. (ELTP)
OTCQB OTCQB Primary 
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.
Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2026 Earnings Call November 17, 2025 11:30 AM EST Company Participants Nasrat Hakim - Chairman, CEO & President Carter Ward - CFO, Secretary & Treasurer Presentation Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal Year 2026 Conference Call. [Operator Instructions] Before management begins speaking, the conference has the following statement.
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth
Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.
2 Outperform Rated Small Caps with Recent Pull-backs
ELTP and TSSI are growth stories with recent material pull-backs.
Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump
ELTP posts record fiscal 2025 revenues and operating income gains, fueled by new launches and expanding generics market share.
Elite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2025 Earnings Conference Call July 1, 2025 11:30 AM ET Company Participants Carter J. Ward - CFO, Secretary & Treasurer Nasrat Hakim - Chairman, CEO & President Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Conference Call.
ELTP Stock Falls Following Q3 Earnings Decline, Revenue Down Y/Y
Elite Pharmaceuticals' third-quarter fiscal 2025 reports a revenue drop and a net loss. However, delayed shipments impact results.
Two Smaller Companies Worthy of Your "Attention"
Here we highlight a small cap and a microcap with Zacks Outperform ratings.
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline
ELTP sees strong revenue growth despite a net loss, driven by new product launches and strategic acquisitions.
Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2025 Earnings Conference Call November 15, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal Year 2025 Conference Call. At this time all lines have been placed on a listen-only mode.
Elite Pharmaceuticals (ELTP) Posts Breakeven Q1 Earnings
Strength in Elite Pharmaceuticals' (ELTP) Manufacturing fees drive its fiscal first-quarter performance.
Elite Pharmaceuticals, Inc. (ELTP) Q1 2025 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2025 Earnings Conference Call August 15, 2024 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Carter Ward – Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals First Quarter of Fiscal Year 2025 Conference Call. At this time, all lines have been placed on a listen-only mode.
